Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02503748
Other study ID # ZH 2015-132
Secondary ID
Status Completed
Phase N/A
First received July 16, 2015
Last updated April 21, 2017
Start date July 2015
Est. completion date February 15, 2017

Study information

Verified date April 2017
Source Zurich University of Applied Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In a participatory process involving urologists and former patients, the project team has developed an online information system ("tutorial") for patients with localized prostate cancer. In this field test, relevant outcomes are measured and the tutorial will be tested for its clinical applicability.


Description:

Prostate cancer is the most common cancer in men: In Switzerland, every year about 6,000 men are diagnosed with prostate cancer. Men with prostate cancer at an early stage are confronted with a difficult decision: they are faced with different treatment alternatives, each with its own advantages and disadvantages. That is why a comprehensive information delivery and processing is extremely important for patients to make an informed decision.

Therefore, an online platform has been developed in collaboration with urologists and former patients. This online platform is designed to cover the individual information needs of patients with early prostate cancer. Additionally, the software aims at facilitating cooperation between patients and doctors and at increasing the satisfaction of patients with their treatment decision.

In this study, the online platform will now to be tested in clinical practice, and data will be collected for the benefit of the platform: Can the online platform actually satisfy the indivudal information needs, facilitate the therapy decision and support the cooperation between doctors and patients?


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date February 15, 2017
Est. primary completion date February 15, 2017
Accepts healthy volunteers No
Gender Male
Age group N/A to 75 Years
Eligibility Medical Inclusion Criteria:

- tumor stage: clinical stage T1 or T2

- PSA level <20 (PSA = Prostata-specific antigen)

- Gleason score <8

- age = 75 years

- Assumed life expectancy = 10 years

Other inclusion criteria due to the study design and the type of intervention are the following:

- patients have to be diagnosed in one of the trial sites

- Internet-enabled device in the patient's household / basal user knowledge of this device

- signing of the consent form

Exclusion Criteria:

- Impaired judgment

- Insufficient ability to read and understand German

- Emotional problems

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Online tutorial
website informing about treatment options in localized prostate cancer

Locations

Country Name City State
Switzerland UrologieZentrum Bern Bern BE
Switzerland Urologie, Kantonsspital Graubünden Chur GR
Switzerland Urologische Universitätsklinik Basel, Kantonsspital Basselland Liestal BL
Switzerland Klinik für Urologie, Luzerner Kantonsspital Luzern LU
Switzerland Urologische Klinik, Kantonsspital Münsterlingen Münsterlingen TG
Switzerland Urologisches Kompetenzzentrum soH Olten SO
Switzerland Klinik für Urologie, Kantonsspital St. Gallen St. Gallen SG
Switzerland Klinik für Urologie, Stadtspital Triemli Zürich ZH

Sponsors (1)

Lead Sponsor Collaborator
Zurich University of Applied Sciences

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary information needs (own scale) questionnaire developed in line with contents of the online tutorial 4 months
Secondary Decision Quality: decisional conflict (Decisional Conflict Scale) 1 month
Secondary Decision Quality: decision regret (Decision Regret Scale) 4 months
Secondary Role in decision making: Preferred Role (Preferred Role in Decision Making Scale) 1 month
Secondary Role in decision making: Actual Role (Actual Role in Decision Making Scale) 4 months
Secondary Preparation for Decision Making (Preparation for Decision Making Scale) 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A